This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-estimates: Archive
EVgo Inc. (EVGO) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
EVgo (EVGO) delivered earnings and revenue surprises of +23.08% and +13.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EVGONegative Net Change AXLPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Shift4 Payments (FOUR) Misses Q2 Earnings Estimates
by Zacks Equity Research
Shift4 Payments (FOUR) delivered earnings and revenue surprises of -8.33% and +0.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FOURNegative Net Change PARNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
GlobalFoundries Inc. (GFS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
GlobalFoundries (GFS) delivered earnings and revenue surprises of +16.67% and +0.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GFSNegative Net Change NVMIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Ocular Therapeutix (OCUL) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -11.43% and -0.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
OCULPositive Net Change PSTVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Bowhead Specialty Holdings Inc. (BOW) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Bowhead Specialty Holdings Inc. (BOW) delivered earnings and revenue surprises of +2.78% and +2.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BOWPositive Net Change HCIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
908 Devices (MASS) delivered earnings and revenue surprises of -12.50% and +7.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MASSPositive Net Change RPIDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Neuronetics (STIM) delivered earnings and revenue surprises of -87.50% and +3.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
STIMPositive Net Change TNDMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
First Watch Restaurant Group, Inc. (FWRG) Q2 Earnings Miss Estimates
by Zacks Equity Research
First Watch Restaurant Group (FWRG) delivered earnings and revenue surprises of -57.14% and +0.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FWRGPositive Net Change EATNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
ImmunityBio (IBRX) delivered earnings and revenue surprises of 0.00% and +0.10%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IBRXNegative Net Change LFCRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
LGI Homes (LGIH) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
LGI Homes (LGIH) delivered earnings and revenue surprises of +12.40% and +1.14%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LGIHNegative Net Change HHHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Camtek (CAMT) Q2 Earnings Meet Estimates
by Zacks Equity Research
Camtek (CAMT) delivered earnings and revenue surprises of 0.00% and +1.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CAMTNegative Net Change KEYSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Tango Therapeutics (TNGX) delivered earnings and revenue surprises of 0.00% and -48.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TNGXPositive Net Change ARCTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
UL Solutions Inc. (ULS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
UL Solutions Inc. (ULS) delivered earnings and revenue surprises of +10.64% and +0.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ULSNegative Net Change BWMNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Knife River (KNF) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Knife River (KNF) delivered earnings and revenue surprises of -29.92% and -3.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KNFPositive Net Change JBINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
LCI (LCII) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
LCI (LCII) delivered earnings and revenue surprises of +7.66% and +2.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LCIINegative Net Change WKHSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Madrigal (MDGL) delivered earnings and revenue surprises of +45.40% and +32.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MDGLPositive Net Change PROFNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sealed Air (SEE) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Sealed Air (SEE) delivered earnings and revenue surprises of +23.61% and +1.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SEEPositive Net Change KRTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AdaptHealth (AHCO) delivered earnings and revenue surprises of -93.33% and -0.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AHCONegative Net Change PBHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AXGNPositive Net Change PRCTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Beam Therapeutics (BEAM) delivered earnings and revenue surprises of +3.85% and -38.59%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BEAMNegative Net Change CVACNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Cushman & Wakefield (CWK) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cushman & Wakefield (CWK) delivered earnings and revenue surprises of +36.36% and +4.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CWKNegative Net Change LEGHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Fidelity National Information Services (FIS) Matches Q2 Earnings Estimates
by Zacks Equity Research
Fidelity National (FIS) delivered earnings and revenue surprises of 0.00% and +1.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FISNegative Net Change DLOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
J&J Snack Foods (JJSF) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
J&J Snack Foods (JJSF) delivered earnings and revenue surprises of +14.94% and +1.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JJSFPositive Net Change HAINNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
AC Immune (ACIU) delivered earnings and revenue surprises of -25.00% and -57.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ACIUNegative Net Change FTREPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Axcelis Technologies (ACLS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Axcelis (ACLS) delivered earnings and revenue surprises of +54.79% and +5.07%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ACLSNegative Net Change VECOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank